Identification of multiple pathways involved in the malignant transformation of endometriosis (Review)

被引:54
作者
Higashiura, Yumi [1 ]
Kajihara, Hirotaka [1 ]
Shigetomi, Hiroshi [1 ]
Kobayashi, Hiroshi [1 ]
机构
[1] Nara Med Univ, Dept Obstet & Gynecol, Kashihara, Nara 6348522, Japan
关键词
endometriosis; ovarian cancer; serous borderline tumor; Mullerian mucinous borderline tumor; adenosarcoma; endometrial stromal sarcoma; CLEAR-CELL CARCINOMA; FEMALE GENITAL-TRACT; MULLERIAN ADENOSARCOMA; OVARIAN-CANCER; BORDERLINE TUMORS; EXTRAOVARIAN ENDOMETRIOSIS; CYSTIC ENDOSALPINGIOSIS; MOLECULAR-MECHANISMS; STROMAL SARCOMAS; OXIDATIVE STRESS;
D O I
10.3892/ol.2012.690
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The association between endometriosis and malignant transformation has often been described in the medical literature. A search was conducted between 1966 and 2010 through the English language literature (online Medline PubMed database) using the keywords endometriosis combined with malignant transformation. The search revealed an increase in reports describing endometriosis and malignancy. Approximately 1.0% of women with endometriosis have lesions that undergo malignant transformation. The malignant processes that are associated with endometriosis may be classified into three groups: i) epithelial ovarian cancers (endometrioid adenocarcinoma and clear cell carcinoma), ii) other Mullerian-type tumors, including Mullerian-type mucinous borderline tumor and serous borderline tumor and iii) sarcomas such as adenosarcoma and endometrial stromal sarcoma in the female pelvic cavity. Persistent oxidative stress induced by endometriosis-dependent hemorrhage may be associated with carcinogenesis. In conclusion, the malignant transformation of endometriosis has multiple pathways of development and may share a common pathogenic mechanism; iron-induced oxidative stress derived from repeated hemorrhage.
引用
收藏
页码:3 / 9
页数:7
相关论文
共 75 条
[1]  
Al-Jefout M, 2009, EXPERT REV OBSTET GY, V4, P61
[2]  
[Anonymous], ISRN OBSTET GYNECOL, DOI DOI 10.5402/2011/140310
[3]   KRAS mutation analysis in ovarian samples using a high sensitivity biochip assay [J].
Auner, Veronika ;
Kriegshaeuser, Gernot ;
Tong, Dan ;
Horvat, Reinhard ;
Reinthaller, Alexander ;
Mustea, Alexander ;
Zeillinger, Robert .
BMC CANCER, 2009, 9
[4]   ENDOMETRIOID STROMAL SARCOMAS ARISING FROM OVARIAN AND EXTRAOVARIAN ENDOMETRIOSIS - REPORT OF 2 CASES AND REVIEW OF THE LITERATURE [J].
BAIOCCHI, G ;
KAVANAGH, JJ ;
WHARTON, JT .
GYNECOLOGIC ONCOLOGY, 1990, 36 (01) :147-151
[5]   PERITONEAL SEROUS MICROPAPILLOMATOSIS OF LOW MALIGNANT POTENTIAL (SEROUS BORDERLINE TUMORS OF THE PERITONEUM) - A CLINICOPATHOLOGICAL STUDY OF 17 CASES [J].
BISCOTTI, CV ;
HART, WR .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1992, 16 (05) :467-475
[6]   Ovarian cancer risk associated with varying causes of infertility [J].
Brinton, LA ;
Lamb, EJ ;
Moghissi, KS ;
Scoccia, B ;
Althuis, MD ;
Mabie, JE ;
Westhoff, CL .
FERTILITY AND STERILITY, 2004, 82 (02) :405-414
[7]   Cancer risk after a hospital discharge diagnosis of endometriosis [J].
Brinton, LA ;
Gridley, G ;
Persson, I ;
Baron, J ;
Bergqvist, A .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1997, 176 (03) :572-579
[8]  
Carlson Joseph, 2008, Diagn Histopathol (Oxf), V14, P352, DOI 10.1016/j.mpdhp.2008.06.009
[9]   Transcript profile and localization of Wnt signaling-related molecules in human endometrium [J].
Cheng, Ching-wen ;
Smith, Stephen K. ;
Charnock-Jones, D. Stephen .
FERTILITY AND STERILITY, 2008, 90 (01) :201-204
[10]   Cytogenetic and molecular aberrations in endometrial stromal tumors [J].
Chiang, Sarah ;
Oliva, Esther .
HUMAN PATHOLOGY, 2011, 42 (05) :609-617